Journal
CELLULAR AND MOLECULAR NEUROBIOLOGY
Volume 39, Issue 7, Pages 1017-1028Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10571-019-00696-2
Keywords
alpha-Synuclein; Astrocytes; Autophagy; Ginkgolide B; Bilobalide
Categories
Funding
- National Natural Science Foundation of China [81673408, 81703485]
Ask authors/readers for more resources
The accumulation of aggregated forms of the alpha-Synuclein (alpha-Syn) is associated with the pathogenesis of Parkinson's disease (PD), and the efficient clearance of aggregated alpha-Syn represents a potential approach in PD therapy. Astrocytes are the most numerous glia cells in the brain and play an essential role in supporting brain functions in PD state. In the present study, we demonstrated that cultured primary astrocytes engulfed and degraded extracellular aggregated recombinant human alpha-Syn. Meanwhile, we observed that the clearance of alpha-Syn by astrocytes was abolished by proteasome inhibitor MG132 and autophagy inhibitor 3-methyladenine (3MA). We further showed that intracellular alpha-Syn was reduced after ginkgolide B (GB) and bilobalide (BB) treatment, and the decrease was reversed by MG132 and 3MA. More importantly, GB and BB reduced indirect neurotoxicity to neurons induced by alpha-Syn-stimulated astrocytic conditioned medium. Together, we firstly find that astrocytes can engulf and degrade alpha-Syn aggregates via the proteasome and autophagy pathways, and further show that GB and BB enhance astrocytic clearance of alpha-Syn, which gives us an insight into the novel therapy for PD in future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available